Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort

被引:5
作者
Brown, Craig S. [2 ]
Lapin, Brittany [1 ]
Wang, Chi [1 ]
Goldstein, Jay L. [1 ]
Linn, John G. [1 ]
Denham, Woody [1 ]
Haggerty, Stephen P. [1 ]
Talamonti, Mark S. [1 ]
Howington, John A. [1 ]
Carbray, Joann [1 ]
Ujiki, Michael B. [1 ]
机构
[1] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL 60201 USA
[2] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2015年 / 29卷 / 12期
关键词
Barrett's esophagus; Esophageal adenocarcinoma; Gastroesophageal reflux disease; Proton-pump inhibitor; PROTON PUMP INHIBITORS; RANDOMIZED CLINICAL-TRIAL; NEOPLASTIC PROGRESSION; ADENOCARCINOMA INCIDENCE; RISK-FACTORS; DYSPLASIA; POPULATION; DISEASE; TRENDS; SURVEILLANCE;
D O I
10.1007/s00464-015-4103-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
It is unknown whether acid/reflux control prevents progression in Barrett's esophagus. In this study, we investigate whether medical or surgical control of reflux is associated with a decreased risk of progression to dysplasia/esophageal adenocarcinoma. We retrospectively collected and analyzed data from a cohort of Barrett's esophagus patients participating in this single-center study comprised of all patients diagnosed with Barrett's esophagus at NorthShore University Health System hospitals and clinics over a 10-year period. Patients were followed in order to identify those progressing from Barrett's esophagus to low-grade dysplasia, high-grade dysplasia, and esophageal adenocarcinoma. We collected information from the patient's electronic medical records regarding demographic, endoscopic findings, histological findings, smoking/alcohol history, medication use including proton-pump inhibitors, and history of bariatric and antireflux surgery. Risk-adjusted modeling was performed using multivariable logistic regression. This study included 1,830 total Barrett's esophagus patients, 102 of which had their Barrett's esophagus progress to low-grade dysplasia, high-grade dysplasia, or esophageal adenocarcinoma (confirmed by biopsy) with an annual incidence rate of 1.1 %. Mean follow-up period was 5.51 years (10,083 patient-years). Compared to the group that did not progress, the group that progressed was older (69.3 +/- A 13.7 vs. 63.9 +/- A 13.4 years. p < 0.001) and likely to be male (75 vs. 61 %, p < 0.01). In the multivariable analysis, patients who had a history of antireflux surgery (n = 44) or proton-pump inhibitor use without surgery (n = 1,641) were found to progress at significantly lower rates than patients who did not have antireflux surgery or were not taking PPI's (OR 0.18, 95 % CI 0.09-0.36). Reflux control was associated with decreased risk of progression to low-grade dysplasia, high-grade dysplasia, or esophageal adenocarcinoma. These results support the use of reflux control strategies such as proton-pump inhibitor therapy or surgery in patients with non-dysplastic Barrett's esophagus for the prevention of progression to dysplasia/adenocarcinoma.
引用
收藏
页码:3528 / 3534
页数:7
相关论文
共 27 条
[1]  
Avidan B, 2002, AM J GASTROENTEROL, V97, P1930, DOI 10.1111/j.1572-0241.2002.05902.x
[2]   Prevalence and Predictors of Columnar Lined Esophagus in Gastroesophageal Reflux Disease (GERD) Patients undergoing upper endoscopy [J].
Balasubramanian, Gokulakrishnan ;
Singh, Mandeep ;
Gupta, Neil ;
Gaddam, Srinivas ;
Giacchino, Maria ;
Wani, Sachin B. ;
Moloney, Brian ;
Higbee, April D. ;
Rastogi, Amit ;
Bansal, Ajay ;
Sharma, Prateek .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (11) :1655-1661
[3]   Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study [J].
Bhat, Shivaram ;
Coleman, Helen G. ;
Yousef, Fouad ;
Johnston, Brian T. ;
McManus, Damian T. ;
Gavin, Anna T. ;
Murray, Liam J. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (13) :1049-1057
[4]   Patient and Physician Satisfaction with Proton Pump Inhibitors (PPIs): Are There Opportunities for Improvement? [J].
Chey, William D. ;
Mody, Reema R. ;
Izat, Esin .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (12) :3415-3422
[5]   Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis [J].
Chiba, N ;
DeGara, CJ ;
Wilkinson, JM ;
Hunt, RH .
GASTROENTEROLOGY, 1997, 112 (06) :1798-1810
[6]   Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006 [J].
Corley, D. A. ;
Kubo, A. ;
Levin, T. R. ;
Block, G. ;
Habel, L. ;
Rumore, G. ;
Quesenberry, C. ;
Buffler, P. .
GUT, 2009, 58 (02) :182-188
[7]   Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study [J].
Crane, Sarah J. ;
Locke, G. Richard, III ;
Harmsen, William S. ;
Zinsmeister, Alan R. ;
Romero, Yvonne ;
Talley, Nicholas J. .
MAYO CLINIC PROCEEDINGS, 2008, 83 (10) :1087-1094
[8]  
Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO
[9]  
2-2
[10]   Dysplasia and risk of further neoplastic progression in a regional veterans administration Barrett's cohort [J].
Dulai, GS ;
Shekelle, PG ;
Jensen, DM ;
Spiegel, BMR ;
Chen, J ;
Oh, D ;
Kahn, KL .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (04) :775-783